These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516 [TBL] [Abstract][Full Text] [Related]
23. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue? Breakey N; Escher R Swiss Med Wkly; 2020 May; 150():w20293. PubMed ID: 32459857 [TBL] [Abstract][Full Text] [Related]
24. Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan. Chen J; Wang X; Zhang S; Lin B; Wu X; Wang Y; Wang X; Yang M; Sun J; Xie Y Clin Appl Thromb Hemost; 2020; 26():1076029620936772. PubMed ID: 32726134 [TBL] [Abstract][Full Text] [Related]
25. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F; Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170 [TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159 [TBL] [Abstract][Full Text] [Related]
27. Clinical findings, risk factors, and final outcome in patients diagnosed with pulmonary thromboembolism and COVID-19 in hospital emergency departments. Jiménez Hernández S; Lozano Polo L; Suñen Cuquerella G; Peña Pardo B; Espinosa B; Cardozo C; Aguirre Tejedo A; Llorens Soriano P; Miró Ò Emergencias; 2020 Ago; 32(4):253-257. PubMed ID: 32692002 [TBL] [Abstract][Full Text] [Related]
28. D-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019: a meta-analysis. Lima WG; Barra A; Brito JCM; Nizer WSC Blood Coagul Fibrinolysis; 2020 Jul; 31(5):335-338. PubMed ID: 32618589 [No Abstract] [Full Text] [Related]
29. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study. Anderson MR; Geleris J; Anderson DR; Zucker J; Nobel YR; Freedberg D; Small-Saunders J; Rajagopalan KN; Greendyk R; Chae SR; Natarajan K; Roh D; Edwin E; Gallagher D; Podolanczuk A; Barr RG; Ferrante AW; Baldwin MR Ann Intern Med; 2020 Nov; 173(10):782-790. PubMed ID: 32726151 [TBL] [Abstract][Full Text] [Related]
30. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count. Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765 [TBL] [Abstract][Full Text] [Related]
31. Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19). Xie Y; You Q; Wu C; Cao S; Qu G; Yan X; Han X; Wang C; Zhang H Circ J; 2020 Jul; 84(8):1277-1283. PubMed ID: 32536672 [TBL] [Abstract][Full Text] [Related]
32. D-dimer level is associated with the severity of COVID-19. Yu HH; Qin C; Chen M; Wang W; Tian DS Thromb Res; 2020 Nov; 195():219-225. PubMed ID: 32777639 [TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids. Carbone F; Montecucco F; Twickler M Eur J Clin Invest; 2020 Jul; 50(7):e13311. PubMed ID: 32511751 [No Abstract] [Full Text] [Related]
34. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary Embolism in Patients Hospitalized With COVID-19 (From a New York Health System). Xu H; Martin A; Singh A; Narasimhan M; Lau J; Weinberg M; Jauhar R; Rao G Am J Cardiol; 2020 Oct; 133():148-153. PubMed ID: 32800295 [TBL] [Abstract][Full Text] [Related]
37. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19. Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 and thrombosis: Beyond a casual association. López Castro J Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683 [No Abstract] [Full Text] [Related]
40. Features of severe COVID-19: A systematic review and meta-analysis. Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]